The demographic and biomedical case for late-life interventions in aging.

Science Translational Medicine
Michael J RaeBarbara J Logan

Abstract

The social and medical costs of the biological aging process are high and will rise rapidly in coming decades, creating an enormous challenge to societies worldwide. In recent decades, researchers have expanded their understanding of the underlying deleterious structural and physiological changes (aging damage) that underlie the progressive functional impairments, declining health, and rising mortality of aging humans and other organisms and have been able to intervene in the process in model organisms, even late in life. To preempt a global aging crisis, we advocate an ambitious global initiative to translate these findings into interventions for aging humans, using three complementary approaches to retard, arrest, and even reverse aging damage, extending and even restoring the period of youthful health and functionality of older people.

References

Jan 1, 1984·Journal of Health Politics, Policy and Law·B A Lockett
Aug 1, 1997·Journal of the American Geriatrics Society·L S SchneiderH C Chui
Mar 19, 2002·Annals of Epidemiology·Robert D AbbottHelen Petrovitch
Apr 27, 2002·Annals of the New York Academy of Sciences·Aubrey D N J de GreyGregory Stock
Dec 23, 2003·Journal of the American Geriatrics Society·Ian JanssenRonenn Roubenoff
Mar 11, 2004·JAMA : the Journal of the American Medical Association·Ali H MokdadJulie L Gerberding
Mar 27, 2004·Proceedings of the National Academy of Sciences of the United States of America·Joseph M DhahbiStephen R Spindler
Jul 17, 2004·Rejuvenation Research·Michael Rae
Sep 7, 2004·Philosophical Transactions of the Royal Society of London. Series B, Biological Sciences·D J P Barker
Feb 9, 2005·The Journals of Gerontology. Series A, Biological Sciences and Medical Sciences·Maggie VergaraRichard A Miller
Mar 1, 2005·Cell·Evan C HadleyRichard J Hodes
Feb 8, 2006·Human Genetics·Jacob vB HjelmborgKaare Christensen
Oct 2, 2008·BMC Geriatrics·Samuel D SearleKenneth Rockwood
Nov 29, 2008·The Journals of Gerontology. Series A, Biological Sciences and Medical Sciences·Bradley J WillcoxLuigi Ferrucci
Dec 11, 2008·BMJ : British Medical Journal·Jane A DriverTobias Kurth
Feb 7, 2009·The Journals of Gerontology. Series A, Biological Sciences and Medical Sciences·James L Kirkland, Charlotte Peterson
Feb 21, 2009·The Journals of Gerontology. Series A, Biological Sciences and Medical Sciences·Judith Campisi, Jan Vijg
Mar 10, 2009·The Journals of Gerontology. Series A, Biological Sciences and Medical Sciences·UNKNOWN Working Group on Functional Outcome Measures for Clinical TrialsMary Parks
Jul 10, 2009·Nature·David E HarrisonRichard A Miller
Sep 19, 2009·Nature·Geoff Brumfiel
Dec 2, 2009·Proceedings of the National Academy of Sciences of the United States of America·Kenneth G MantonGene Lowrimore
Apr 30, 2010·Rejuvenation Research·Leonid A Gavrilov, Natalia S Gavrilova

❮ Previous
Next ❯

Citations

Jun 4, 2011·The Journals of Gerontology. Series A, Biological Sciences and Medical Sciences·Christy S CarterDrake Morgan
Oct 10, 2012·Experimental Gerontology·Philip McDonaldRobert Arking
Oct 30, 2010·BioEssays : News and Reviews in Molecular, Cellular and Developmental Biology·Caleb E Finch, Steven N Austad
Mar 24, 2016·Progress in Neurobiology·David Blokh, Ilia Stambler
Feb 3, 2015·The Journal of Physiology·Douglas R SealsThomas J LaRocca
Apr 4, 2012·Expert Opinion on Drug Discovery·Vladimir N AnisimovMaria N Yurova
Jun 2, 2015·Aging and Disease·David Blokh, Ilia Stambler
Aug 9, 2011·Mechanisms of Ageing and Development·Lene Juel RasmussenVilhelm A Bohr
Sep 29, 2011·PloS One·André C R Martins
Oct 31, 2012·Molecular Aspects of Medicine·Niki ChondrogianniEfstathios S Gonos
Dec 22, 2015·Cell Metabolism·Christopher D WileyJudith Campisi
Jul 27, 2010·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·Mathilde JalvingElisabeth G E de Vries
Aug 30, 2017·GeroScience·David BlokhEliyahu H Mizrahi
Nov 22, 2014·The British Journal of Nutrition·John C Mathers
Aug 21, 2018·Rejuvenation Research·Colin Farrelly
Sep 24, 2015·Nutrition Research Reviews·Sibylle NikolaiGerald Rimbach
Sep 15, 2015·Topics in Geriatric Rehabilitation·Philip S RequejoSara J Mulroy
Jan 11, 2014·Journal of Applied Physiology·Amy L SindlerDouglas R Seals
Sep 10, 2019·Aging Cell·Gregory M FahySteve Horvath
Dec 14, 2019·Aging Cell·Luigi FerrucciRafael de Cabo
Jul 25, 2020·The Journal of Clinical Endocrinology and Metabolism·Anthony S ZannasDavid R Rubinow
Dec 19, 2019·Frontiers in Cell and Developmental Biology·Eleanor R SteadIvana Bjedov
Oct 21, 2020·Circulation. Genomic and Precision Medicine·Erik B van den AkkerP Eline Slagboom
Feb 3, 2021·The Journals of Gerontology. Series A, Biological Sciences and Medical Sciences·Colin Farrelly
May 8, 2021·Expert Review of Endocrinology & Metabolism·Maryam KebbeLeanne M Redman
May 6, 2021·Politics and the Life Sciences : the Journal of the Association for Politics and the Life Sciences·Colin Farrelly
Jul 25, 2021·Ageing Research Reviews·Tesfahun Dessale AdmasuAlexandra Stolzing
Aug 8, 2021·International Journal of Environmental Research and Public Health·Ben Y F FongTing Yu Lam
Aug 10, 2021·Annual Review of Sociology·Iliya Gutin, Robert A Hummer

❮ Previous
Next ❯

Related Concepts

Related Feeds

Allogenic & Autologous Therapies

Allogenic therapies are generated in large batches from unrelated donor tissues such as bone marrow. In contrast, autologous therapies are manufactures as a single lot from the patient being treated. Here is the latest research on allogenic and autologous therapies.